Literature DB >> 28164853

Impact of Antibiotics on Necrotizing Enterocolitis and Antibiotic-Associated Diarrhea.

Michael A Silverman1, Liza Konnikova2, Jeffrey S Gerber3.   

Abstract

Antibiotic treatment alters the composition and metabolic function of the intestinal microbiota. These alterations may contribute to the pathogenesis of necrotizing enterocolitis (NEC) and antibiotic-associated diarrhea (AAD). Recent studies are beginning to unravel the contribution of specific groups of microbes and their metabolic pathways to these diseases. Probiotics or other microbiota-targeted therapies may provide effect strategies to prevent and treat NEC and AAD.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotic-associated diarrhea; Antibiotics; Clostridium difficile; Microbiome; Necrotizing enterocolitis; Probiotics

Mesh:

Substances:

Year:  2017        PMID: 28164853      PMCID: PMC5314436          DOI: 10.1016/j.gtc.2016.09.010

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  98 in total

1.  Influence of mode of delivery on gut microbiota composition in seven year old children.

Authors:  S Salminen; G R Gibson; A L McCartney; E Isolauri
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

2.  Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.

Authors:  Vincent B Young; Thomas M Schmidt
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

Review 3.  Role of the gut microbiota in defining human health.

Authors:  Kei E Fujimura; Nicole A Slusher; Michael D Cabana; Susan V Lynch
Journal:  Expert Rev Anti Infect Ther       Date:  2010-04       Impact factor: 5.091

4.  Clostridium difficile infection: historic review.

Authors:  John G Bartlett
Journal:  Anaerobe       Date:  2009-09-12       Impact factor: 3.331

5.  Caesarean section delivery and the risk of allergic disorders in childhood.

Authors:  H Renz-Polster; M R David; A S Buist; W M Vollmer; E A O'Connor; E A Frazier; M A Wall
Journal:  Clin Exp Allergy       Date:  2005-11       Impact factor: 5.018

6.  Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis.

Authors:  Vanaja N Alexander; Veronika Northrup; Matthew J Bizzarro
Journal:  J Pediatr       Date:  2011-04-13       Impact factor: 4.406

7.  Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial.

Authors:  Kate Costeloe; Pollyanna Hardy; Edmund Juszczak; Mark Wilks; Michael R Millar
Journal:  Lancet       Date:  2015-11-28       Impact factor: 79.321

8.  Strain-resolved community genomic analysis of gut microbial colonization in a premature infant.

Authors:  Michael J Morowitz; Vincent J Denef; Elizabeth K Costello; Brian C Thomas; Valeriy Poroyko; David A Relman; Jillian F Banfield
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-29       Impact factor: 11.205

9.  Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns.

Authors:  Maria G Dominguez-Bello; Elizabeth K Costello; Monica Contreras; Magda Magris; Glida Hidalgo; Noah Fierer; Rob Knight
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

10.  Development of the human infant intestinal microbiota.

Authors:  Chana Palmer; Elisabeth M Bik; Daniel B DiGiulio; David A Relman; Patrick O Brown
Journal:  PLoS Biol       Date:  2007-06-26       Impact factor: 8.029

View more
  31 in total

1.  Bacterial diversity in intestinal mucosa of antibiotic-associated diarrhea mice.

Authors:  Guozhen Xie; Kai Tan; Maijiao Peng; Chengxing Long; Dandan Li; Zhoujin Tan
Journal:  3 Biotech       Date:  2019-11-09       Impact factor: 2.406

Review 2.  Progress in Diagnosis and Treatment of Neonatal Sepsis: A Review Article.

Authors:  Pratibha Yadav; Shailendra Kumar Yadav
Journal:  JNMA J Nepal Med Assoc       Date:  2022-03-11       Impact factor: 0.556

3.  Regulatory Effect of Lactiplantibacillus plantarum 2-33 on Intestinal Microbiota of Mice With Antibiotic-Associated Diarrhea.

Authors:  Wuyundalai Bao; Yuxing He; Jinghe Yu; Mingchao Liu; Xiaofeng Yang; Na Ta; Enxin Zhang; Chengyuan Liang
Journal:  Front Nutr       Date:  2022-06-09

4.  The Impact of Maternal Antibiotics on Neonatal Disease.

Authors:  Benjamin D Reed; Kurt R Schibler; Hitesh Deshmukh; Namasivayam Ambalavanan; Ardythe L Morrow
Journal:  J Pediatr       Date:  2018-03-16       Impact factor: 4.406

5.  Effect of Debaryomyces hansenii combined with Qiweibaizhu powder extract on the gut microbiota of antibiotic-treated mice with diarrhea.

Authors:  Guozhen Xie; Yi Wu; Tao Zheng; Kejia Shen; Zhoujin Tan
Journal:  3 Biotech       Date:  2020-02-20       Impact factor: 2.406

6.  Clinical benefits of introducing real-time multiplex PCR for cerebrospinal fluid as routine diagnostic at a tertiary care pediatric center.

Authors:  Anna Eichinger; Alexandra Hagen; Melanie Meyer-Bühn; Johannes Huebner
Journal:  Infection       Date:  2018-09-05       Impact factor: 3.553

Review 7.  Perspectives from the Society for Pediatric Research: Probiotic use in urinary tract infections, atopic dermatitis, and antibiotic-associated diarrhea: an overview.

Authors:  Catherine S Forster; Michael H Hsieh; Michael D Cabana
Journal:  Pediatr Res       Date:  2020-12-07       Impact factor: 3.756

Review 8.  Insight Into Host-Microbe Interactions Using Microbial Flow Cytometry Coupled to Next-Generation Sequencing.

Authors:  Michael A Silverman; Jamal L Green
Journal:  J Pediatric Infect Dis Soc       Date:  2021-12-24       Impact factor: 3.164

Review 9.  The triune of intestinal microbiome, genetics and inflammatory status and its impact on the healing of lower gastrointestinal anastomoses.

Authors:  Jou A Lee; Timothy J A Chico; Stephen A Renshaw
Journal:  FEBS J       Date:  2017-12-22       Impact factor: 5.542

10.  A retrospective study of probiotics for the treatment of children with antibiotic-associated diarrhea.

Authors:  Xue Rui; Shu-Xia Ma
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.